A model for co-expression pattern analysis of genes implicated in angiogenesis and tumour cell invasion in cervical cancer

British Journal of Cancer

Volumn 87, Issue 5, 2002, Pages 537-544

  Van Trappen, P O ^a   Ryan, A ^a   Carroll, M ^a   Lecoeur, C ^a   Goff, L ^b   Gyselman, V G ^a   Young, B D ^b   Lowe, D G ^a   Pepper, M S ^c   Shepherd, J H ^a   Jacobs, I J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Angiogenesis; Cervical cancer; Co expression pattern analysis; Tumour cell invasion

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; RNA 18S; THROMBOSPONDIN 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MODEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; UTERINE CERVIX CANCER;

CERVIX UTERI; ENDOTHELIAL GROWTH FACTORS; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOKINES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, GENETIC; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE INITIATION FACTORS; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, RIBOSOMAL, 18S; TRANSCRIPTION, GENETIC; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 18544372930     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600471     Document Type: Article

References (44)

1. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
2. Distribution of the 72-kd type IV collagenase in nonneoplastic and neoplastic thyroid tissue
3. Angiogenesis in cancer and other diseases
4. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
5. Eif4E expression in tumors: Its possible role in progression of malignancies
6. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology
7. Expression profiling using cDNA microarrays
8. Cluster analysis and display of genome-wide expression patterns
9. The vascular endothelial growth factor family of polypeptides
10. Incipient angiogenesis
11. Tumor angiogenesis: Therapeutic implications
12. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers
13. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
14. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
15. Real time quantitative PCR
16. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA
17. Hyperplasia of lypmatic vessels in VEGF-C transgenic mice
18. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: Implications for tumor angiogenesis
19. Vascular endothelial growth factor is implicated in early invasion in cervical cancer
20. Array of hope
21. Molecular profiling of human cancer
22. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
23. Vascular endothelial growth factor-C mediated lymphangiogenesis promotes tumour metastasis
24. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer
25. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer
26. Current biology of VEGF-B and VEGF-C
27. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
28. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis Lung Carcinoma
29. Expression of cell-associated isoform of vascular endothelial growth factor 189 and its prognostic relevance in non-small cell lung cancer
30. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis
31. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor
32. Quantitative monitoring of gene expression patterns with a complementary DNA microarray
33. Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E
34. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis
35. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics
36. Different angiogenic pathways in human cervical cancers
37. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer
38. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
39. Molecular quantification and mapping of lymph node micrometastases in cervical cancer
40. Lymphatic dissemination of tumour cells and the formation of tumour micrometastases
41. VEGFs, receptors and angiogenesis
42. Inhibition of angiogenesis by thrombospondin-2
43. Vascular-specific growth factors and blood vessel formation
44. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells